ALISO VIEJO, Calif., Jan. 2 (HSMN NewsFeed) — Valeant Pharmaceuticals International (NYSE: VRX ) today announced that effective December 31, 2008, the company completed its acquisition of Dow Medical Sciences, Inc., a privately held dermatology c…
Biopharmaceuticals, Acquisitions, Dermatology
Valeant Pharmaceuticals International, Dow Pharma Sciences

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Valeant Pharmaceuticals Completes Acquisition of Dow Lab Sciences, Inc.”
Leave a Comment